Clinical Trials and Therapeutic Approaches for Healthcare Challenges in Pakistan

Author:

Ahmed Aamir12,Williams Norman R.3ORCID

Affiliation:

1. ONCOLODYNE Ltd., 71–75 Shelton Street, Covent Garden, London WC2H 9JQ, UK

2. Cell and Developmental Biology, University College London, Gower Street, London WC1E 6JJ, UK

3. UCL Division of Surgery & Interventional Science, 3rd Floor, Charles Bell House, 43–45 Foley Street, London W1W 7TY, UK

Abstract

Pakistan faces tremendous challenges in providing healthcare due to a lack of consistent policymaking, increasing expenditure and exponential growth in population since its inception in 1947. These challenges are not just driven by politics, policy and allocation of resources but also by healthcare, environment and characteristics of the population biology. Clinical trials provide the best way to find population-specific, cost-effective treatments that do not merely mimic those used in wealthier nations. This article analyzes all clinical studies conducted with at least one site in Pakistan listed on ClinicalTrials.gov, combined with a short overview that considers new therapeutic approaches that can be investigated in future clinical trials. Therapies using repurposed medicines are of particular interest as they use affordable drugs that are already widely available.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference32 articles.

1. (2023, August 27). Home|Pakistan Bureau of Statistics, Available online: https://www.pbs.gov.pk/.

2. (2023, September 02). World Bank Open Data. Available online: https://data.worldbank.org.

3. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis from the Global Burden of Disease Study 2016;Fullman;Lancet,2018

4. The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries;Singer;Int. J. Breast Cancer,2017

5. (2023, September 02). About ClinicalTrials.Gov|ClinicalTrials.Gov, Available online: https://clinicaltrials.gov/about-site/about-ctg.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3